Related Experiment Video

Updated: Jan 26, 2026

Handheld Metal Detector Screening for Metallic Foreign Body Ingestion in Children
04:55

Handheld Metal Detector Screening for Metallic Foreign Body Ingestion in Children

Published on: September 11, 2018

11.2K

Body Surface Area-Based Dosing Regimen of Caspofungin in Children: a Population Pharmacokinetics Confirmatory Study

Xin-Mei Yang1, Stephanie Leroux2,3, Thomas Storme2

  • 1Department of Pharmacy, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, China.

Antimicrobial Agents and Chemotherapy
|April 17, 2019
PubMed

Insights

Caspofungin dosing in children (2-12 years) is best guided by body surface area, not weight. This pharmacokinetic study confirms BSA-based adjustments ensure appropriate pediatric dosing for this antifungal medication.

Area of Science:

  • Pharmacokinetics and Pharmacodynamics
  • Pediatric Pharmacology
  • Antifungal Drug Research

Background:

  • Caspofungin is a key antifungal agent used in pediatric populations.
  • Optimal dosing strategies are crucial for efficacy and safety in children.
  • Existing pharmacokinetic data in pediatric patients require further elucidation.

Purpose of the Study:

  • To characterize the population pharmacokinetics of caspofungin in children aged 2 to 12 years.
  • To identify key covariates influencing caspofungin exposure in this age group.
  • To establish evidence-based dosing recommendations for pediatric caspofungin therapy.

Main Methods:

  • Real-world pharmacokinetic data from 48 pediatric patients were analyzed.
  • A two-compartment model with first-order elimination was employed.
  • Covariate analysis was performed to identify factors influencing drug disposition.

Main Results:

  • The population pharmacokinetic model indicated a two-compartment structure with first-order elimination.
  • Body surface area (BSA) was identified as a significant covariate, outperforming body weight.
  • Significant correlation found between BSA and caspofungin pharmacokinetics.

Conclusions:

  • Population pharmacokinetics of caspofungin in children (2-12 years) support BSA-based dosing.
  • Adjusting caspofungin dosage by body surface area is the most appropriate strategy for pediatric use.
  • This finding aids in optimizing antifungal treatment for pediatric patients.

Keywords:
caspofunginchildrendevelopmental pharmacokineticsdose

More Related Videos

Studying Brain Function in Children Using Magnetoencephalography08:00

Studying Brain Function in Children Using Magnetoencephalography

Published on: April 8, 2019

9.6K
Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs10:02

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs

Published on: July 23, 2016

33.3K

Related Concept Videos

Dosage Regimen: Fixed Dose01:01

Dosage Regimen: Fixed Dose

Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
2.3K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
720
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
159
Rational Dosage Regimen: Maintenance Dose and Loading Dose01:24

Rational Dosage Regimen: Maintenance Dose and Loading Dose

A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
5.5K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
266
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
698